AN UNBIASED VIEW OF CONOLIDINE

These final results, along with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the notion of targeting ACKR3 as a singular way to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Diseases.We independently exploration, evaluate, and